HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

por Meitz, J C, Edwards, S M, Easton, D F, Murkin, A, Ardern-Jones, A, Jackson, R A, Williams, S, Dearnaley, D P, Stratton, M R, Houlston, R S, Eeles, R A
Publicado 2002